Abstract
Effectiveness of standard treatments in non-small-cell lung cancer with METexon14 skipping mutation: a real-world study
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have